Table 2 Pre-treatment clinical information, treatment modality, and follow-up information for 37 patients with morphological evidence of no treatment effect in prostate cancer at salvage radical prostatectomy.
Clinical, treatment-modality and follow up information | Number (%) |
---|---|
Median age in years | 69 (range, 54–78) |
Median PSA (ng/ml) at diagnosis | 5.15 (range, 3.1–12) |
Biopsy grade group | |
1 | 16 (43) |
2 | 9 (24) |
3 | 2 (5) |
4 | 1 (3) |
5 | 1 (3) |
NA | 8 (21) |
Median percent core involvement | 33 (range, 5–90) |
Type of radiation treatment | |
IMRT | 12 |
Brachytherapy | 9 |
XRT | 3 |
Brachytherapy + XRT | 2 |
Proton therapy | 1 |
HDR | 1 |
NA | 9 |
Androgen deprivation therapy | |
Yes | 13 |
No | 19 |
Median time in months from dx to recurrence | 6 (range, 1–17) |
Median time in months from dx to salvage RP | 7 (range, 1–17) |